Inventor · disambiguated record
Thore Hettmann
Also filed as: HETTMANN THORE · HETTMANN THORE A O
11 granted patents·5 pending applications·49 citations·filing 2006–2022
86Inventor score
Files withDAIICHI SANKYO EUROPE GMBH5DAIICHI SANKYO CO LTD3HETTMANN THORE3U3 PHARMA GMBH2MERCK PATENT GMBH1
Top patents by PatentIndex Score
16 records- 0190US10383878B2Anti-HER3 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Aug 20, 2019·29 cites·17 claims
- 0282US9101760B2Material and methods for treating or preventing HER-3 associated diseasesHETTMANN THORE·Filed 2010·Granted Aug 11, 2015·7 cites·36 claims
- 0378US9988462B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2016·Granted Jun 5, 2018·2 cites·31 claims
- 0478US9803025B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2013·Granted Oct 31, 2017·3 cites·38 claims
- 0576US8933202B2AXL antibodiesHETTMANN THORE·Filed 2008·Granted Jan 13, 2015·7 cites·28 claims
- 0667US12139549B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2017·Granted Nov 12, 2024·0 cites·20 claims
- 0765US10357566B2HER3 inhibitor for modulating radiosensitivityDAIICHI SANKYO EUROPE GMBH·Filed 2013·Granted Jul 23, 2019·1 cites·21 claims
- 0859US11351259B2HER3 inhibitor for modulating radiosensitivityDAIICHI SANKYO EUROPE GMBH·Filed 2019·Granted Jun 7, 2022·0 cites·23 claims
- 0957US11298359B2Anti-HER3 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2019·Granted Apr 12, 2022·0 cites·17 claims
- 1057US8828382B2Heparin-binding epidermal growth factor-like growth factor binding proteinsROTHE MIKE·Filed 2008·Granted Sep 9, 2014·0 cites·10 claims
- 1152US2007104689A1Compositions and methods for treating tumors presenting survivin antigensMERCK PATENT GMBH·Filed 2006·Application pending·0 cites
- 1249US12043659B2Humanized and de-immunized antibodiesVIVORYON THERAPEUTICS N V·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
- 1345US2015152193A1Axl antibodiesU3 PHARMA GMBH·Filed 2014·Application pending·0 cites
- 1445US2022172420A1Anti-her3 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 1545US2016009796A9Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding ProteinsU3 PHARMA GMBH·Filed 2014·Application pending·0 cites
- 1636US2012156130A1Use of her3 binding agents in prostate treatmentHETTMANN THORE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thore Hettmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →